| Teva Pharmaceutical Industries Limited | 1.5M | US$50.8M | 6.6% |
| Mineralys Therapeutics, Inc. | 1.47M | US$39.7M | 5.2% |
| Syndax Pharmaceuticals, Inc. | 1.01M | US$22.2M | 2.9% |
| Biogen Inc. | 96,626 | US$20.9M | 2.7% |
| Ultragenyx Pharmaceutical Inc. | 588K | US$19.6M | 2.6% |
| Biomarin Pharmaceutical Inc. | 329K | US$18.8M | 2.5% |
| Cytokinetics, Incorporated | 220K | US$18.7M | 2.4% |
| Bridgebio Pharma, Inc. | 245K | US$18.3M | 2.4% |
| Cogent Biosciences, Inc. | 459K | US$17.8M | 2.3% |
| Insmed Incorporated | 119K | US$12.7M | 1.7% |
| Maze Therapeutics, Inc. | 418K | US$12.5M | 1.6% |
| Sanofi Sa | 270K | US$11.5M | 1.5% |
| Cybin, Inc. | 1.62M | US$10.7M | 1.4% |
| Eli Lilly And Company | 8,040 | US$9.64M | 1.3% |
| Madrigal Pharmaceuticals, Inc. | 17,419 | US$9.35M | 1.2% |
| Trevi Therapeutics, Inc. | 499K | US$9.31M | 1.2% |
| Acadia Pharmaceuticals Inc. | 357K | US$9.02M | 1.2% |
| Celldex Therapeutics, Inc. | 241K | US$8.96M | 1.2% |
| Rhythm Pharmaceuticals, Inc. | 80,400 | US$8.93M | 1.2% |
| Oric Pharmaceuticals, Inc. | 753K | US$8.15M | 1.1% |
| Lam Research Corporation | 18,470 | US$8M | 1.0% |
| Applied Materials, Inc. | 11,040 | US$7.98M | 1.0% |
| Tango Therapeutics, Inc. | 254K | US$7.95M | 1.0% |
| Novartis Ag | 50,000 | US$7.83M | 1.0% |
| Vor Biopharma Inc. | 416K | US$7.67M | 1.0% |
| Abbvie Inc. | 30,256 | US$7.61M | 0.99% |
| Merck & Company, Inc. | 58,600 | US$7.53M | 0.98% |
| Johnson & Johnson | 28,831 | US$7.32M | 0.96% |
| Ideaya Biosciences, Inc. | 196K | US$7.32M | 0.95% |
| Nuvectis Pharma, Inc. | 383K | US$7.04M | 0.92% |
| Pfizer, Inc. | 286K | US$6.89M | 0.90% |
| Harmony Biosciences Holdings, Inc. | 177K | US$6.43M | 0.84% |
| Xenon Pharmaceuticals Inc. | 105K | US$6.34M | 0.83% |
| Climb Bio, Inc. | 484K | US$6.31M | 0.82% |
| Zenas Biopharma, Inc. | 231K | US$5.86M | 0.76% |
| Novo Nordisk A/s Class B | 121K | US$5.79M | 0.75% |
| Enliven Therapeutics, Inc. | 113K | US$5.72M | 0.75% |
| Prelude Therapeutics Incorporated | 1.02M | US$5.44M | 0.71% |
| Gsk Plc | 102K | US$5.35M | 0.70% |
| Forte Biosciences, Inc. | 250K | US$5.31M | 0.69% |
| Bioage Labs, Inc. | 214K | US$5.24M | 0.68% |
| Scholar Rock Holding Corporation | 94,265 | US$5.18M | 0.68% |
| Satellos Bioscience Inc | 653K | US$5.07M | 0.66% |
| Palisade Bio, Inc. | 2.26M | US$4.72M | 0.62% |
| Eledon Pharmaceuticals, Inc. | 1.19M | US$4.69M | 0.61% |
| Vistra Corp. | 29,450 | US$4.67M | 0.61% |
| Talen Energy Corporation | 12,135 | US$4.66M | 0.61% |
| Savara, Inc. | 756K | US$4.66M | 0.61% |
| Disc Medicine, Inc. | 63,538 | US$4.65M | 0.61% |
| Dyne Therapeutics, Inc. | 200K | US$4.43M | 0.58% |
| Relay Therapeutics, Inc. | 234K | US$4.38M | 0.57% |
| Avalo Therapeutics, Inc. | 232K | US$4.29M | 0.56% |
| Promis Neurosciences Inc. | 326K | US$4.28M | 0.56% |
| Biocryst Pharmaceuticals, Inc. | 422K | US$4.22M | 0.55% |
| Revolution Medicines, Inc. | 22,400 | US$4.2M | 0.55% |
| Cabaletta Bio, Inc. | 1.33M | US$4.13M | 0.54% |
| Generate Biomedicines, Inc. | 245K | US$4.13M | 0.54% |
| Alpha Cognition Inc. | 546K | US$3.94M | 0.51% |
| Corvus Pharmaceuticals, Inc. | 245K | US$3.66M | 0.48% |
| Ovid Therapeutics Inc. | 1.35M | US$3.64M | 0.47% |
| Bridgebio Oncology Therapeutics, Inc. | 461K | US$3.51M | 0.46% |
| Cytomx Therapeutics, Inc. | 879K | US$3.3M | 0.43% |
| Alnylam Pharmaceuticals, Inc. | 10,800 | US$3.25M | 0.42% |
| Kura Oncology, Inc. | 295K | US$3.24M | 0.42% |
| Kodiak Sciences Inc | 81,796 | US$3.19M | 0.42% |
| Ormat Technologies, Inc. | 28,015 | US$3.05M | 0.40% |
| Contineum Therapeutics, Inc. | 183K | US$3.01M | 0.39% |
| Larimar Therapeutics, Inc. | 926K | US$2.82M | 0.37% |
| Immix Biopharma, Inc. | 270K | US$2.78M | 0.36% |
| Amgen Inc. | 7,500 | US$2.72M | 0.35% |
| Biohaven Ltd. | 164K | US$2.45M | 0.32% |
| Constellation Energy Corporation | 9,850 | US$2.45M | 0.32% |
| Verastem, Inc. | 633K | US$2.42M | 0.32% |
| Tenax Therapeutics, Inc. | 120K | US$1.75M | 0.23% |
| Taysha Gene Therapies, Inc. | 250K | US$1.7M | 0.22% |
| Upstream Bio, Inc. | 220K | US$1.52M | 0.20% |
| Voyager Therapeutics, Inc. | 428K | US$1.5M | 0.20% |
| Organogenesis Holdings Inc. | 550K | US$1.34M | 0.17% |
| Inhibikase Therapeutics, Inc. | 649K | US$1.32M | 0.17% |
| Shattuck Labs, Inc. | 86,461 | US$600K | 0.08% |
| First Tracks Biotherapeutics, Inc. | 27,876 | US$561K | 0.07% |
| Skye Bioscience, Inc. | 679K | US$471K | 0.06% |
| Traws Pharma, Inc. | 398K | US$336K | 0.04% |
| Evommune, Inc. | 22,632 | US$301K | 0.04% |
| Werewolf Therapeutics, Inc. | 627K | US$226K | 0.03% |
| Aprea Therapeutics, Inc. | 270K | US$217K | 0.03% |
| Precision Biosciences, Inc. | 0 | US$0 | 0.00% |
| Solaredge Technologies, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Amazon.com, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Applied Optoelectronics, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Bristol-myers Squibb Company | 0 | US$0 | 0.00% |
| Curis, Inc. | 0 | US$0 | 0.00% |
| Enphase Energy, Inc. | 0 | US$0 | 0.00% |
| Foghorn Therapeutics Inc. | 0 | US$0 | 0.00% |
| Nice Ltd. | 0 | US$0 | 0.00% |
| Palo Alto Networks, Inc. | 0 | US$0 | 0.00% |